Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Must Biotechnology is a professional supplier specializing in the research, development, and distribution of traditional Chinese medicine (TCM) reference standards, high-purity plant monomers, and imported reagents. Established in 2007 and based in Chengdu, China, the company operates a joint laboratory for TCM standard sample development in collaboration with the Chengdu Institute of Biology, Chinese Academy of Sciences. Equipped with advanced analytical and purification instruments such as NMR, Q-TOF mass spectrometers, and preparative HPLC, Chengdu Must Biotechnology provides over 1,000 high-quality reference standards to research institutions, universities, pharmaceutical companies, and drug testing departments worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Must Biotechnology.